Avoid Rapid Dose Escalation Increasing doses too quickly may increase the chance of nausea, fatigue, or headaches
We are adding new 425.118(b)(3)(i) to require an ACO to submit the change request and supporting documentation according to the form and manner specified by CMS
Book your NAD+ IM Shot appointment online today at Restore Hyper Wellness in South Portland, ME
BPC-157 and TB-500 Dosage Protocol BPC-157: 250500mcg daily, injected subcutaneously near the injury site TB-500: 22.5mg twice weekly (loading phase) for 46 weeks, then 2mg once weekly (maintenance phase) The combination is typically used for 612 weeks, depending on injury severity and healing progress
Under the policies being finalized, ACOs inexperienced with performance-based risk Medicare ACO initiatives (defined at 425.20) will progress more rapidly to higher levels of risk and potential reward under Level E of the BASIC track or the ENHANCED track (if eligible), compared to existing policies
TB-500 itself has essentially no completed human trials
